|

bezuclastinib Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CGT9486, PLX9486

Pipeline

Phase 2: 1

Top Sponsors

  • Cogent Biosciences, Inc.1

Indications

  • Aggressive Systemic Mastocytosis (ASM)1
  • Mast Cell Leukemia (MCL)1
  • SM With an Associated Hematologic Neoplasm (SM-AHN)1
  • Advanced Systemic Mastocytosis (AdvSM)1
  • Cancer1

Birmingham, Alabama1 trial

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

University of Alabama at Birmingham (UAB) Hospital

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.